Medical & Scientific Advisors : Update : 19 went down to 5 ..... and on the cusp of "SunRise" we now have the addition of 4.
How sweet it is!
I've been seeing "David Carbone" through my list of research for "MONTHS!" and after looking at his background/history/affiliates many times before, I never would have never, ever have expected his name to fill a void on this Peregrines website. All of them are highly respected and I only mention David Carbone because for some reason, through all that research.... his name continued to pop up and he lands at Peregrine.
BAMM.... that bumpy road Dr. Garnick talked about many months ago has simply smoothed out a bit...
If you follow the chain of posts back... you'll see everyone was split between Medical/Scientic/Infectious-Antiviral/ Advisors and now we have one happy group all lumped under:
Dr. Philip E. Thorpe .... RIP and hopefully approves of the new and final? list
* = part of original team of advisors
** = replaced Dr. Philip E. Thorpe
*** = part of the new addition of 4 just added 12/10/2013
Medical and Scientific Advisors:
*** Scott J. Antonia, M.D., Ph.D. Department Chair, Program Leader, Thoracic Oncology Department Associate Professor Department of Interdisciplinary Oncology and Program Leader of the Immunology Program H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
** Rolf Brekken, Ph.D. Associate Professor, Hamon Center for Therapeutic Oncology Research UT Southwestern Medical Center
*** David Carbone, M.D., Ph.D. Professor of Medicine, Division of Medical Oncology Ohio State University’s Ohio State’s Comprehensive Cancer Center at the James Cancer Hospital and Solove Research Institute, Columbus, Ohio
* Bruce Chabner, M.D. Clinical director of Massachusetts General Hospital (MGH) Cancer Center Chief of Hematology and Oncology at MGH and a Professor of Medicine at Harvard Medical School
* Harold F. Dvorak, M.D. Chief of the Department of Pathology at Beth Israel Deaconess Medical Center Mallinckrodt Professor of Pathology at Harvard Medical School
*** Dimitry I. Gabrilovich, M.D., Ph.D. Christopher M. Davis Professor in Cancer Research, Program Leader, Translational Tumor Immunology The Wistar Institute, Philadelphia, Pennsylvania
* Christopher C. W. Hughes, Ph.D. Professor, Departments of Molecular Biology and Biochemistry, & Biomedical Engineering University California Irvine
*** Håkan Mellstedt, M.D., Ph.D. Professor of Oncologic Biotherapy, Karolinska Institute and Cancer Centre Karolinska Karolinska University Hospital, Stockholm, Sweden
* Alan J. Schroit, Ph.D. Professor of Cancer Biology M.D. Anderson Cancer Center, Houston
News 
Market Data 
Discover 
